156
Views
2
CrossRef citations to date
0
Altmetric
Immunopathogenesis of Asthma

IgG Immune Complex Induces the Recruitment of Inflammatory Cells into the Airway and TNF-Mediated Late Airway Hyperresponsiveness via NF-κB Activation in Mice

, B.S., , Ph.D., , M.D., Ph.D., , M.S., , M.S., , Ph.D., , M.D., Ph.D., , M.S., , Ph.D., , M.D., Ph.D. & , M.D., Ph.D. show all
Pages 757-766 | Published online: 22 Aug 2011

References

  • Barnes PJ. Cytokine-directed therapies for the treatment of chronic airway diseases. Cytokine Growth Factor Rev 2003; 14:511–522.
  • Barnes PJ, Adock IA. Transcription factors and asthma. Eur Respir J 1998; 12:221–234.
  • Blackwell TS, Christman JW. The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol 1997; 17:3–9.
  • Baldwin AS Jr. The NF-κB and IκB proteins: New discoveries and insights. Annu Rev Immunol 1996; 14:649–683.
  • Stutz AM, Woisetschlager M. Functional synergism of STAT6 with either NF-κB or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription. J Immunol 1999; 16:4383–4391.
  • Mori A, Kaminuma O, Mikami T, Inoue S, Okumura Y, Akiyama K, Okudaira H. Transcriptional control of the IL-5 gene by human helper T cells: IL-5 synthesis is regulated independently from IL-2 or IL-4 synthesis. J Allergy Clin Immunol 1999; 103:429–436.
  • Barnes PJ, Adcock IM. NF-kappa B: A pivotal role in asthma and a new target for therapy. Trends Pharmacol Sci 1997; 18:46–50.
  • Zhu YX, Kang LY, Luo W, Li CC, Yang L, Yang YC. Multiple transcription factors are required for activation of human interleukin 9 gene in T cells. J Biol Chem 1996; 271:15815–15822.
  • Washizu J, Nishimura H, Nakamura N, Nimura Y, Yoshikai Y. The NF-κB binding site is essential for transcriptional activation of the IL-15 gene. Immunogenetics 1998; 48:1–7.
  • Yang L, Cohn L, Zhang DH, Homer R, Ray A, Ray P. Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation. J Exp Med 1998; 188:1739–1750.
  • Donovan CE, Mark DA, He HZ, Liou HC, Kobzik L, Wang Y, De Sanctis GT, Perkins DL, Finn PW. NF-κB/Rel transcription factors: c-Rel promotes airway hyperresponsiveness and allergic pulmonary inflammation. J Immunol 1999; 163:6827–6833.
  • Das J, Chen CH, Yang L, Cohn L, Ray P, Ray A. A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat Immunol 2001; 2:45–50.
  • Desmet C, Gosset P, Pajak B, Cataldo D, Bentires-Alj M, Lekeux P, Bureau F. Selective blockade of NF-kappa B activity in airway immune cells inhibits the effector phase of experimental asthma. J Immunol 2004; 173:5766–5775.
  • Choi IW, Kim DK, Ko HM, Lee HK. Administration of antisense phosphorothioate oligonucleotide to the p65 subunit of NF-κB inhibits established asthmatic reaction in mice. Int Immunopharmacol 2004; 4:1817–1828.
  • Lee HK, Lee HH, Park YM, Park HJ, Lee JH, Ha TY. Anti-IL-4 antibody inhibits antigen specific IgE response but fails to prevent chicken gamma globulin-induced active systemic anaphylaxis: Evidence for the involvement of IgG antibodies. J Korean Med Sci 1996; 11:111–117.
  • Choi IW, Kim S, Kim YS, Ko HM, Im SY, Kim JH, You HJ, Lee YC, Lee JH, Park YM, Lee HK. TNF-alpha induces the late-phase airway hyperresponsiveness and airway inflammation through cytosolic phospholipase A2 activation. J Allergy Clin Immunol 2005; 116:537–543.
  • Eum SY, Maghni K, Hamid Q, Campbell H, Eidelman DH, Martin JG. Involvement of the cysteinyl-leukotrienes in allergen-induced airway eosinophilia and hyperresponsiveness in the mouse. Am J Respir Cell Mol Biol 2003; 28:25–32.
  • Choi IW, Kim YS, Kim DK, Choi JH, Seo KH, Im SY, Kwon KS, Lee MS, Ha TY, Lee HK. Platelet-activating factor–mediated NF-kappa B dependency of a late anaphylactic reaction. J Exp Med 2003; 198:145–151.
  • Lentsch AB, Czermak BJ, Bless NM, Ward PA. NF-kappa B activation during IgG immune complex-induced lung injury: Requirements for TNF-alpha and IL-1 but not complement. Am J Pathol 1998; 152:1327–1336.
  • Guo RF, Lentsch AB, Warner RL, Huber-Lang M, Sarma JV, Hlaing T, Shi MM, Lukacs NW, Ward PA. Regulatory effects of eotaxin on acute lung inflammatory injury. J Immunol 2001; 166:5208–5218.
  • Gómez-Guerrero C, López-Franco O, Suzuki Y, Sanjuán G, Hernández-Vargas P, Blanco J, Egido J. Nitric oxide production in renal cells by immune complexes: Role of kinases and nuclear factor-κB. Kidney Int 2002; 62:2022–2034.
  • Suzuki Y, Gómez-Guerrero C, Shirato I, López-Franco O, Gallego-Delgado J, Sanjuán G, Lázaro A, Hernández-Vargas P, Okumura K, Tomino Y, Ra C, Egido J. Pre-existing glomerular immune complexes induce polymorphonuclear cell recruitment through an Fc receptor-dependent respiratory burst: Potential role in the perpetuation of immune nephritis. J Immunol 2003; 170:3243–3253.
  • Ishizaka T, Ishizaka K. Activation of mast cells for mediator release through IgE receptors. Prog Allergy 1984; 34:188–235.
  • Im SY, Han SJ, Ko HM, Choi JH, Chun SB, Lee DG, Ha TY, Lee HK. Involvement of nuclear factor-kappa B in platelet-activating factor-mediated tumor necrosis factor-alpha expression. Eur J Immunol 1997; 27:2800–2804.
  • Ko HM, Seo KH, Han SJ, Ahn KY, Choi IH, Koh GY, Lee HK, Ra MS, Im SY. Nuclear factor kappaB dependency of platelet-activating factor-induced angiogenesis. Cancer Res 2002; 62:1809–1814.
  • Choi IW, Kim YS, Kim DK, Choi JH, Seo KH, Im SY, Kwon KS, Lee MS, Ha TY, Lee HK. Platelet-activating factor-mediated NF-kappaB dependency of a late anaphylactic reaction. J Exp Med 2003; 198:145–151.
  • Kawano T, Matsuse H, Kondo Y, Machida I, Saeki S, Tomari S, Mitsuta K, Obase Y, Fukushima C, Shimoda T, Kohno S. Cysteinyl leukotrienes induce nuclear factor kappa b activation and RANTES production in a murine model of asthma. J Allergy Clin Immunol 2003; 112:369–374.
  • Tomari S, Matsuse H, Machida I, Kondo Y, Kawano T, Obase Y, Fukushima C, Shimoda T, Kohno S. Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, attenuates allergen-specific tumour necrosis factor alpha production and nuclear factor kappa b nuclear translocation in peripheral blood monocytes from atopic asthmatics. Clin Exp Allergy 2003; 33:795–801.
  • Grimbaldeston MA, Chen CC, Piliponsky AM, Tsai M, Tam SY, Galli SJ. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 2005; 167:835–848.
  • Dessaint JP, Capron A. IgE and inflammatory cells: The cellular networks in allergy. Int Arch Allergy Appl Immunol 1989; 1:28–31.
  • Capron M, Capron A, Goetzl EJ, Austen KF. Tetrapeptides of the eosinophil chemotactic factor of anaphylaxis (ECF-A) enhance eosinophil Fc receptor. Nature 1981; 289:71–73.
  • Zuberi RI, Apgar JR, Chen SS, Liu FT. Role for IgE in airway secretions: IgE immune complexes are more potent inducers than antigen alone of airway inflammation in a murine model. J Immunol 2000; 164:2667–2673.
  • Taube C, Dakhama A, Rha YH, Takeda K, Joetham A, Park JW, Balhorn A, Takai T, Poch KR, Nick JA, Gelfand EW. Transient neutrophil infiltration after allergen challenge is dependent on specific antibodies and FcgIII receptors. J Immunol 2003; 170:4301–4309.
  • Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999; 60:1532–1539.
  • Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, Chu HW. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999; 160:1001–1008.
  • Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma: Evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001; 119:1329–1336.
  • Chakir J, Hamid Q, Bosse M, Boulet LP, Laviolette M. Bronchial inflammation in corticosteroid-sensitive and corticosteroid-resistant asthma at baseline and on oral corticosteroid treatment. Clin Exp Allergy 2002; 32:578–582.
  • Bentley AM, Hamid Q, Robinson DS, Schotman E, Meng Q, Assoufi B, Kay AB, Durham SR. Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med 1996; 153:551–556.
  • Nguyen LT, Lim S, Oates T, Chung KF. Increase in airway neutrophils after oral but not inhaled corticosteroid therapy in mild asthma. Respir Med 2005; 99:200–207.
  • Monteseirín J. Neutrophils and asthma. J Investig Allergol Clin Immunol 2009; 19:340–354.
  • Castro AC, Dang LC, Soucy F, Grenier L, Mazdiyasni H, Hottelet M, Parent L, Pien C, Palombella V, Adams J. Novel IKK inhibitors: Beta-carbolines. Bioorg Med Chem Lett 2003; 13:2419–2422.
  • Kim YS, Ko HM, Kang NI, Song CH, Zhang X, Chung WC, Kim JH, Choi IH, Park YM, Kim GY, Im SY, Lee HK. Mast cells play a key role in the development of late airway hyperresponsiveness through TNF-alpha in a murine model of asthma. Eur J Immunol 2007; 37:1107–1115.
  • Heller T, Gessner JE, Schmidt RE, Klos A, Bautsch W, Köhl J. Cutting edge: Fc receptor type I for IgG on macrophages and complement mediate the inflammatory response in immune complex peritonitis. J Immunol 1999; 162:5657–5661.
  • Baumann U, Köhl J, Tschernig T, Schwerter-Strumpf K, Verbeek JS, Schmidt RE, Gessner JE. A codominant role of Fc gamma RI/III and C5aR in the reverse Arthus reaction. J Immunol 2000; 164:1065–1070.
  • Chouchakova N, Skokowa J, Baumann U, Tschernig T, Philippens KM, Nieswandt B, Schmidt RE, Gessner JE. Fc gamma RIII-mediated production of TNF-α induces immune complex alveolitis independently of CXC chemokine generation. J Immunol 2001; 166:5193–5200.
  • Clynes R, Maizes JS, Guinamard R, Ono M, Takai T, Ravetch JV. Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J Exp Med 1999; 189:179–185.
  • Sánchez-Mejorada G, Rosales C. Fc gamma receptor-mediated mitogen-activated protein kinase activation in monocytes is independent of Ras. J Biol Chem 1998; 273:27610–27619.
  • Rittirsch D, Flierl MA, Day DE, Nadeau BA, Zetoune FS, Sarma JV, Werner CM, Wanner GA, Simmen HP, Huber-Lang MS, Ward PA. Cross-talk between TLR4 and FcgammaRIII (CD16) pathways. PLoS Pathog 2009; 5:e1000464.
  • Kanke T, Macfarlane SR, Seatter MJ, Davenport E, Paul A, McKenzie RC, Plevin R. Proteinase-activated receptor-2-mediated activation of stress-activated protein kinases and inhibitory kappa B kinases in NCTC 2544 keratinocytes. J Biol Chem 2001; 276:31657–31661.
  • Gringhuis SI, den Dunnen J, Litjens M, van Het Hof B, van Kooyk Y, Geijtenbeek TB. C-type lectin DC-SIGN modulates toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappa B. Immunity 2007; 26:605–616.
  • Schmidlin F, Amadesi S, Dabbagh K, Lewis DE, Knott P, Bunnett NW, Gater PR, Geppetti P, Bertrand C, Stevens ME. Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway. J Immunol 2002; 169:5315–5321.
  • Zhou Y, Kawasaki H, Hsu SC, Lee RT, Yao X, Plunkett B, Fu J, Yang K, Lee YC, Huang SK. Oral tolerance to food-induced systemic anaphylaxis mediated by the C-type lectin SIGNR1. Nat Med 2010; 16:1128–1133.
  • Mulligan MS, Jones ML, Bolanowski MA, Baganoff MP, Deppeler CL, Meyers DM, Ryan US, Ward PA. Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody. J Immunol 1993; 150:5585–5595.
  • Mulligan MS, Schmid E, Beck-Schimmer B, Till GO, Friedl HP, Brauer RB, Hugli TE, Miyasaka M, Warner RL, Johnson KJ, Ward PA. Requirement and role of C5a in acute lung inflammatory injury in rats. J Clin Invest 1996; 98:503–512.
  • Mulligan MS, Vaporciyan AA, Warner RL, Jones ML, Foreman KE, Miyasaka M, Todd RF 3rd, Ward PA. Compartmentalized roles for leukocytic adhesion molecules in lung inflammatory injury. J Immunol 1995; 154:1350–1363.
  • Czermak BJ, Lentsch AB, Bless NM, Schmal H, Friedl HP, Ward PA. Synergistic enhancement of chemokine generation and lung injury by C5a or the membrane attack complex of complement. Am J Pathol 1999; 154:1513–1524.
  • Czermak BJ, Sarma V, Bless NM, Schmal H, Friedl HP, Ward PA. In vitro and in vivo dependency of chemokine generation on C5a and TNF-alpha. J Immunol 1999; 162:2321–2325.
  • Lukacs NW, Glivsky MM, Ward PA. Complement-dependent immune complex-induced bronchial inflammation and hyperreactivity. Am J Physiol Lung Cell Mol Physiol 2001; 280:L512–L518.
  • Garssen J, Nijkamp FP, Van Der Vliet H, Van Loveren H. T-cell-mediated induction of airway hyperreactivity in mice. Am Rev Respir Dis 1991; 144:931–938.
  • Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999; 17:255–281.
  • Okayama Y, Kirshenbaum AS, Metcalfe DD. Expression of a functional high-affinity IgG receptor, Fc gamma RI, on human mast cells: up-regulation by IFN-gamma. J Immunol 2000; 164:4332–4339.
  • van de Winkel JG, Anderson CL. Biology of human immunoglobulin G Fc receptors. J Leukoc Biol 1991; 49:511–524.
  • Thomas PS, Yates DH, Barnes PJ. Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med 1995; 152:76–80.
  • Thomas PS, Heywood G. Effects of inhaled tumor necrosis factor-alpha in subjects with mild asthma. Thorax 2002; 57:774–778.
  • Howarth PH, Babu KS, Arshad H, Lau L, Buckley M, McConnell W, Beckett P, Al Ali M, Chauhan A, Wilson SJ, Reynolds A, Davies DE, Holgate ST. Tumour necrosis factor (TNF-alpha) as a novel therapeutic target in symptomatic corticosteroid-dependent asthma. Thorax 2005; 60:1012–1018.
  • Berry MA, Hargadon B, Shelley M, Parker D, Shaw DE, Green RH, Bradding P, Brightling CE, Wardlaw AJ, Pavord ID. Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med 2006; 354:697–708.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.